Loading viewer...
investor_presentation
Format: PDF investor_presentation
Datto's October 2020 investor presentation prepared for its initial public offering, containing financial information as of December 31, 2019 and interim results through June 30, 2020. The presentation includes market analysis, financial metrics including Adjusted EBITDA, and forward-looking statements regarding the company's business operations and growth prospects.
investor_presentation
38 Pages
investor_presentation
16 Pages
Corporate Travel Management
Iovance Biotherapeutics Investor Presentation — March 2019
investor_presentationinvestor_presentation
27 Pages
Iovance Biotherapeutics, Inc